Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML (2009)

Author(s): Malladi R, Peniket A, Littlewood T, Towlson K, Pearce R, Yin J, Cavenagh J, Craddock C, Orchard K, Olavarria E, McQuaker G, Collin M, Marks D

      • Journal: Bone Marrow Transplantation
      • Volume: 43
      • Issue: 9
      • Pages: 709-715
      • Publisher: Nature Publishing Group
      • Publication type: Article
      • Bibliographic status: Published

      Professor Matthew Collin
      Professor of Haematology